Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to Do a Continuous Inverting Bowel Anastomosis Employing Counter-Traction.

ANZ journal of surgery·2026
Same author

Interventional, surgical, and clinical management of Abernethy malformations: A case series and novel anatomic variant.

Radiology case reports·2026
Same author

Autonomous Hazardous Gas Detection Systems: A Systematic Review.

Sensors (Basel, Switzerland)·2025
Same author

Quantitative Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Radioembolization.

Investigative radiology·2025
Same author

Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.

Radiology·2025
Same author

Robotic Resection of an Idiopathic Azygos Vein Aneurysm and the Diagnostic Role of Thoracic Venogram.

Innovations (Philadelphia, Pa.)·2025

Related Experiment Videos

Optional vena cava filter use in the elderly population.

Colette M Shaw1, Leslie B Scorza, Peter N Waybill

  • 1Department of Interventional Radiology, Penn State Heart and Vascular Institute, Penn State Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA. cshaw39@gmail.com

Journal of Vascular and Interventional Radiology : JVIR
|May 3, 2011
PubMed
Summary
This summary is machine-generated.

Optional inferior vena cava (IVC) filters are safe and effective for patients 65 and older. Age is not a barrier to successful filter removal with proper selection and follow-up.

Related Experiment Videos

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Geriatric Medicine

Background:

  • Inferior vena cava (IVC) filters are used to prevent pulmonary embolism (PE).
  • The use and retrieval rates of optional IVC filters in elderly patients require further investigation.

Purpose of the Study:

  • To evaluate the utility, safety, and efficacy of optional IVC filters in patients aged 65 years and older.
  • To compare outcomes between optional and permanent IVC filters in this age group.

Main Methods:

  • Retrospective review of patients aged 65+ who received optional or permanent IVC filters.
  • Comparison of technical success, recurrent PE, thrombotic complications, and filter retrieval rates.
  • Analysis of retrieval rates in optional filter recipients compared to a general cohort.

Main Results:

  • Technical success rates for optional and permanent filters were comparable (98.1% vs. 99.8%).
  • Pulmonary embolism rates were low in both groups (0% optional vs. 1.4% permanent).
  • Deep vein thrombosis rates were higher in the optional filter group (12% vs. 4.5%), but not statistically significant (P = .06).
  • Filter retrieval was attempted in 55.6% of optional filter recipients, similar to younger patients.

Conclusions:

  • Optional IVC filters demonstrate safety and efficacy in patients aged 65 years and older.
  • Age alone is not a reliable indicator for predicting the opportunity for filter removal.
  • Achieving high retrieval rates comparable to younger populations is feasible with appropriate patient selection and diligent follow-up.